Teresa Grossi, N.P.
NPI 1700935103 · Nurse Practitioner · Valencia, CA
Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1700935103
- Entity type
- Individual
- Primary specialty
- Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
- Credential
- N.P.
- Sex
- Female
- Sole proprietor
- Yes
- License
- NP15948 (CA)
Specialties & taxonomies
Physician Assistants & Advanced Practice Nursing Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
3 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
3,541 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 1,748 | $6 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 711 | $82 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 384 | $51 |
| Destruction of Skin Growth, 1-14 Growths17110 | 255 | $108 |
| New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203 | 95 | $101 |
| Biopsy of Related Skin Growth, First Growth |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 18 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Mometasone Furoate | 126 | 96 |
| Fluorouracil | 60 | 57 |
| Mupirocin | 50 | 40 |
| Fluocinonide | 50 | 32 |
| Triamcinolone Acetonide | 48 | 21 |
| Ciclopirox Olaminebrand: Ciclopirox | 46 | 27 |
| Clobetasol Propionate | 40 | 17 |
| Econazole Nitrate | 40 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$997 across 39 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (2)
- 2438 N Ponderosa Dr Ste C105Camarillo, CA 93010-2465Phone: (805) 388-2068Fax: (805) 484-7700
- 1700 N Rose Ave Ste 450Oxnard, CA 93030-7628Phone: (805) 201-7150Fax: (805) 278-0137
Registry dates
- Enumerated
- 2007-01-09
- Last updated
- 2020-11-06
- Certified
- 2020-11-06
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.